← Evidence map

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.

Xiao-Ming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33854184